
Candel Therapeutics, Inc. (CADL)
CADLNASDAQHealthcareBiotechnology
$5.04Today:−$0.19 (−3.57%)1Y +12.75%
As of Nov 20, 2026 close
- Market cap
- $396.99M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $4.35$14.00
- Volume (live)
- -
- Avg. volume (3M)
- 1.44M
ETFs Holding Candel Therapeutics (CADL)
1 US ETF holds CADL among its top 50 positions: BBC with 0.92% in CADL.
US ETFs with CADL in Their Top 50 Holdings
Sorted by fund assets
Based on each fund's top 50 holdings; funds holding CADL below their top 50 are not listed.
| ETF | Name | Weight | AUM | Expense Ratio |
|---|---|---|---|---|
| BBC | Virtus Biotech Clinical Trials ETF | 0.92% | $42.32M | 0.65% |
Source: ETF top holdings as reported by fund issuers (largest ~50 positions per fund). Data sources and methodology
Frequently Asked Questions
How many ETFs hold CADL?
1 US ETF holds CADL among its top 50 positions. Funds that hold CADL outside their top 50 positions are not counted.
Which ETF has the highest weight in CADL?
BBC (Virtus Biotech Clinical Trials ETF) has the highest CADL weight among these funds at 0.92% of its assets.